Trademark Overview
On Wednesday, August 27, 2008, a trademark application was filed for REGENCIN with the United States Patent and Trademark Office. The USPTO has given the REGENCIN trademark a serial number of 77556560. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, September 17, 2008. This trademark is owned by Pfizer Inc.. The REGENCIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research in the field of genetics, genetic engineering, biotechnology, and regenerative medicine; development of new technology and processes and biological, biomedical and biochemical preparations and solutions, namely, cell preparations, enzymes, proteins, hormones, microbes, molecules and reagents for others in the fields of genetics, genetic engineering, biotechnology, and regenerative medicine